The Cannabis Conversations: Part II with Anna Lembke MD

As public acceptance of cannabis has increased, so has the use of it, but it’s not all good. As the use of cannabis has increased, so has the misuse of cannabis. As with any other psychoactive chemical, the misuse of cannabis can lead to a variety of harmful effects: psychosis, dependence, tolerance, and in a subset of vulnerable individuals, even addiction.

In Part II of the “Cannabis Conversations,” mental health and addiction expert, Dr. Anna Lembke, joins the podcast to talk about the use and misuse of cannabis in vulnerable populations, the increased addictive potential of today’s cannabis, and the increasing use of cannabis in the treatment of opioid addiction. We also discuss the growing debilitating problem among chronic heavy cannabis users: Cannabinoid Hyperemesis Syndrome.

About Our Guest

Dr. Anna Lembke is a diplomate of the American Board of Psychiatry and Neurology, and a diplomate of the American Board of Addiction Medicine. She is the Program Director for the Stanford University Addiction Medicine Fellowship, and Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic.

Dr. Lembke has published over fifty peer-reviewed articles, chapters, and commentaries, and is the author of the book: Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop.